# FDA Inspection 1141315 - Cardinal Health 414 LLC - April 07, 2021

Source: https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/773d7765-d0a5-4f27-a3db-858866ddcf49
Source feed: FDA_Inspections

> FDA Inspection 1141315 for Cardinal Health 414 LLC on April 07, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1141315
- Company Name: Cardinal Health 414 LLC
- Inspection Date: 2021-04-07
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1310776 - 2026-02-20](https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/d6e1a7a6-23a6-4763-a14a-594f4d754d41)
- [FDA Inspection 1310776 - 2026-02-20](https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/cf70bc3b-4742-4e93-bd1c-2261f94c1362)
- [FDA Inspection 953336 - 2015-09-29](https://www.keypedia.com/records/fda_inspections/cardinal-health-414-llc/96211e11-2416-40ec-856e-573879fb888d)

Company: https://www.keypedia.com/companies/cardinal-health-414-llc/6bdfe0bc-ec38-4dee-832e-c3cd7fa1e6ce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c